Pay in 4 interest-free payments of $5.40 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
The Danger Zones: Freezing and Heat While we often worry about medication getting too warm, getting too cold is equally dangerous
Which Alternative Is Right for You
Food and Drug Administration (FDA) approved Zepbound (tirzepatide) for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related condition, such as high blood pressure or type 2 diabetes
In the US, Wegovy is approved for use in individuals with a BMI over 30 with no other co-morbidities and 27 in individuals with a weight-related condition, such as hypertension
Wilding JPH, Kwan AYM, Maldonado JM, Wang H, Rasouli N (2022) Tirzepatide induces weight loss in patients with type 2 diabetes regardless of baseline BMI: a post hoc analysis of SURPASS-1 through SURPASS-5 studies
US$ 28.60
US$ 29.07
US$ 24.98
